abstract |
A pharmaceutical composition containing a fatty acid compound of the formula R-CO-Y with R as omega-x-poly acid residue where x = 3-9 and a total carbon number between C 17 and C 23 and a number of isolated double bonds between 3 and 6 (eg gammalinolenic acid, arachidonic acid , Omega-3-docosahexaenoic acid). Y may be either a biogenic amine of structure -NH-R 'or a simple derivative thereof or a biogenic alcohol of structure -OR' or a simple derivative thereof. The biogenic amine is, for example, a decarboxylated natural amino acid AS or a simple derivative thereof from the series Val, Ileu, Leu, Pro, Hypro, Arg, CyS-SCy, Met, Lys, Hylys, Orn, Trp, His. As the active substance, a fatty acid amide is formed accordingly. The biogenic alcohol is derived from a decarboxylated natural amino acid of the series Ala, Val, Ileu, Leu, Phe, Hypro, Arg, Thr, Cys, CyS-SCy, Met, Lys, Hylys, Orn, Trp and His. As an active substance, a fatty acid ester is formed accordingly. The drug is used as an active ingredient to combat diseases and disorders such as depression, anxiety, pain, spasm, vomiting, hypertension, dyskinesia, insomnia, migraine, asthma, schizophrenia, multiple sclerosis, appetite stimulation. |